Autifony Therapeutics Competitors and Similar CompaniesClear all
Autifony Therapeutics's competitors and similar companies include moksha8 Pharmaceuticals, Ethismos Research, Silo Pharma and Delix Therapeutics.
 Autifony Therapeutics Autifony Therapeutics is a biotechnology company that develops new drugs to treat serious disorders of the central nervous system. |  moksha8 Pharmaceuticals Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders. |  Ethismos Research Ethismos Research is a drug discovery company developing therapies to address addiction and depression. |  Silo Pharma Silo Pharma is a developmental stage biopharmaceutical company focusing on merging traditional therapeutics with psychedelic research for people suffering from neurological disorders. |  Delix Therapeutics Delix Therapeutics is a company developing small molecule drug compounds against mental disorders. | |
Founding Date | Founding Date 2011 | Founding Date 2006 | Founding Date N/A | Founding Date 2010 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Stevenage, GB HQ Padova, IT | Locations Berwyn, US HQ Ciudad De México, MX | Locations Cambridge, US HQ | Locations Englewood Cliffs, US HQ | Locations HQ |
Employees | Employees 3017% decrease | Employees 370 | Employees 18 | Employees 350% increase | Employees 313% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) £22.8m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $72.1k (FY, 2025) | Revenue (est.) N/A |
Net income | Net income £16.2m (FY, 2018) | Net income N/A | Net income N/A | Net income ($4.2m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 12.3m (almost 11 years ago) | Latest funding round $ 125m (over 13 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 70m (over 4 years ago) |
Total funding raised | Total funding raised $ 24.2m | Total funding raised $ 224.1m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 78m |
For sources of this data, please see the company profile
View Company Profiles
moksha8 Pharmaceuticals
HQ
Berwyn, US
Employees
370
Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders.
View companyEthismos Research
HQ
Cambridge, US
Employees
18
Ethismos Research is a drug discovery company developing therapies to address addiction and depression.
View companySilo Pharma
HQ
Englewood Cliffs, US
Employees
3↑ 50% increase
Silo Pharma is a developmental stage biopharmaceutical company focusing on merging traditional therapeutics with psychedelic research for people suffering from neurological disorders.
View companyDelix Therapeutics
HQ
Employees
31↓ 3% decrease
Delix Therapeutics is a company developing small molecule drug compounds against mental disorders.
View company